Phosphodiesterase 4 Inhibitors for the Treatment of COPD
- 1 May 2002
- journal article
- review article
- Published by Elsevier BV in Chest
- Vol. 121 (5), 192S-196S
- https://doi.org/10.1378/chest.121.5_suppl.192s
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Suppression of human inflammatory cell function by subtype‐selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4BBritish Journal of Pharmacology, 1999
- Effect of High Dose Inhaled Steroid on Cells, Cytokines, and Proteases in Induced Sputum in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue SmokingNew England Journal of Medicine, 1999
- Inhibition of tumor necrosis factor-α induced neutrophil apoptosis by cyclic AMP: involvement of caspase cascadeEuropean Journal of Pharmacology, 1999
- EUROSCOP, ISOLDE and the Copenhagen City Lung StudyThorax, 1999
- Nicotinamide derivatives as selective inhibitors of PDE4Expert Opinion on Therapeutic Patents, 1999
- Phosphodiesterase IsozymesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?Trends in Pharmacological Sciences, 1997
- Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.American Journal of Respiratory and Critical Care Medicine, 1997
- Biarylcarboxylic Acids and -amides: Inhibition of Phosphodiesterase Type IV versus [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the FerretJournal of Medicinal Chemistry, 1996